Related Articles
Several types of soft tissue sarcomas originate from the malignant transformation of adipose tissue-derived stem cells
Management of recurrent or refractory Ewing sarcoma: A systematic review of phase II clinical trials in the last 15 years
lncRNA <em>HAR1B</em> has potential to be a predictive marker for pazopanib therapy in patients with sarcoma Corrigendum in /10.3892/ol.2021.12959
Emerging therapies in thymic epithelial tumors (Review)
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)